Cancer research saves lives and leads to improved outcomes for patients. But federal cancer research funding may be in jeopardy for 2026.

Study participants are enrolled in cohorts based on their tumor types (e.g., an advanced solid tumor), the genomic alterations of their tumors, and the targeted drug (s) matched to those alterations ...

Background: Mantle Cell Lymphoma (MCL) is generally treated with rituximab (R) in combination with other drugs. However, treatment for relapsed or refractory (RR) MCL is challenging. For Ibrutinib ...

Introducing the ASCO Meetings mobile app, one of your new resources for navigating the Annual Meeting. The app enables you to search sessions and presentation details, read abstracts, view posters, ...

An overview of ASCO’s flagship Leadership Development Program timeline and curriculum for the upcoming application cycle, including eligibility criteria for prospective applicants.

Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It allows for greater transparency in the ASCO ...

Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the ...

A systematic review of the literature on telehealth in oncology was performed, including the use of technologies and telecommunications systems, and other electronic methods of care delivery and ...

The following page details the abstract submission guidelines and requirements for the 2025 ASCO Annual Meeting. All types of oncology-related research are eligible for submission. The details below ...

Conquer Cancer®, the ASCO Foundation and Pfizer External Research & Grants are collaborating to offer a Quality Improvement grant funding opportunity to improve the patient experience in bladder ...

Starting January 1, 2021, there will be significant changesto the office and outpatient Evaluation and Management (E&M) services Current Procedural Terminology (CPT ®) codes (99202-99215), for both ...